← Eichor
Condition: Transthyretin Amyloidosis Polyneuropathy Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Transthyretin Amyloidosis Polyneuropathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Exercise Training in Transthyretin Cardiac Amyloidosis
NA · 1 location(s) · Brigham and Women's Hospital · NCT05797857ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Phase N/A · 40 location(s) · Alnylam Pharmaceuticals · NCT04561518Description of a Retrospective Cohort of Patients With Transthyretin Cardiac Amyloidosis (ATTR-CA) in Internal Medicine
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT06907836To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transth
Phase 4 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT06940336Prevalence of Wild-type TTR Cardiac Amyloidosis in Patients With Polyneuropathy of Unknown Cause.
NA · 1 location(s) · Universitair Ziekenhuis Brussel · NCT05950867Essen Amyloidosis Registry
Phase N/A · 1 location(s) · University Hospital, Essen · NCT06887283A Non-interventional Cohort Safety Study of Patients With hATTR-PN
Phase N/A · 26 location(s) · Akcea Therapeutics · NCT04850105TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidos
Phase 3 · 41 location(s) · Alnylam Pharmaceuticals · NCT07223203ATTR Amyloid Cardiomyopathy: Characterization of Extracellular Vesicles as Potential Disease Stratifiers and Prognostic
Phase N/A · 1 location(s) · University of Sao Paulo General Hospital · NCT07314268A Phase 3 Study of NTLA-2001 in ATTRv-PN
Phase 3 · 14 location(s) · Intellia Therapeutics · NCT06672237A Phase I/IIa，Open-label, Single Ascending Dose and Dose-expansion Clinical Study to Evaluate the Safety, Tolerability,
Phase 1/Phase 2 · 3 location(s) · YolTech Therapeutics Co., Ltd · NCT06539208Longitudinal Quantitative Neuromuscular MRI in Neuropathic Patients
NA · 1 location(s) · Assistance Publique Hopitaux De Marseille · NCT06845644Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients Wit
Phase N/A · 1 location(s) · University of Texas Southwestern Medical Center · NCT07196839Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt)
Phase 1/Phase 2 · 1 location(s) · Steen Hvitfeldt Poulsen · NCT06318260Multimodality Cardiac Imaging for Disease Progression in ATTR-CM
NA · 1 location(s) · Dominik Benz · NCT07112066US Benchmarking Clinical Study
Phase N/A · 3 location(s) · eMyosound SAS · NCT07215715Genistein in trAnSthyretin recePtor Amyloid caRdiomyopathy
Phase 1/Phase 2 · 1 location(s) · London Health Sciences Centre Research Institute OR Lawson R · NCT06634108Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
Phase N/A · 3 location(s) · University of Texas Southwestern Medical Center · NCT05489549NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis
Phase N/A · 1 location(s) · Paolo Milani · NCT06251778Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Phase N/A · 6 location(s) · Columbia University · NCT06034405Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Phase N/A · 82 location(s) · AstraZeneca · NCT06465810Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
Phase N/A · 7 location(s) · Alnylam Pharmaceuticals · NCT05040373Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
Phase N/A · 4 location(s) · Intellia Therapeutics · NCT05697861Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Patho
Phase 3 · 103 location(s) · Eidos Therapeutics, a BridgeBio company · NCT06563895Quantitative Analysis of Myocardial Uptake of Bone Radiopharmaceuticals in Patients With Cardiac ATTR Amyloidosis
NA · 2 location(s) · University Hospital, Caen · NCT04535349
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.